ICARES Medicus, Inc. (6612.TWO)

TWD 118.0

(0.0%)

EBITDA Summary of ICARES Medicus, Inc.

  • ICARES Medicus, Inc.'s latest annual EBITDA in 2023 was 165.54 Million TWD , down -0.08% from previous year.
  • ICARES Medicus, Inc.'s latest quarterly EBITDA in 2024 Q2 was 55.23 Million TWD , down -8.01% from previous quarter.
  • ICARES Medicus, Inc. reported an annual EBITDA of 174.42 Million TWD in 2022, up 64.75% from previous year.
  • ICARES Medicus, Inc. reported an annual EBITDA of 105.87 Million TWD in 2021, up 2.21% from previous year.
  • ICARES Medicus, Inc. reported a quarterly EBITDA of 55.23 Million TWD for 2024 Q2, down -8.01% from previous quarter.
  • ICARES Medicus, Inc. reported a quarterly EBITDA of 13.74 Million TWD for 2023 Q4, down -75.99% from previous quarter.

Annual EBITDA Chart of ICARES Medicus, Inc. (2023 - 2019)

Historical Annual EBITDA of ICARES Medicus, Inc. (2023 - 2019)

Year EBITDA EBITDA Growth
2023 165.54 Million TWD -0.08%
2022 174.42 Million TWD 64.75%
2021 105.87 Million TWD 2.21%
2020 103.57 Million TWD -15.11%
2019 122.01 Million TWD 0.0%

Peer EBITDA Comparison of ICARES Medicus, Inc.

Name EBITDA EBITDA Difference
St.Shine Optical Co.,Ltd. 1.01 Billion TWD 83.627%
Bioteque Corporation 736.13 Million TWD 77.512%
Chi Sheng Pharma & Biotech Co., Ltd 117.55 Million TWD -40.824%
Sunder Biomedical Tech. Co., Ltd. 76.61 Million TWD -116.074%
BenQ Medical Technology Corporation 532.15 Million TWD 68.892%
Pacific Hospital Supply Co., Ltd 673.8 Million TWD 75.432%
Unicon Optical Co., Ltd. 377.24 Million TWD 56.119%
Formosa Optical Technology Co.,Ltd. 1.04 Billion TWD 84.166%
Medeon Biodesign, Inc. -1.14 Billion TWD 114.497%
Concord Medical Co., Ltd. 137.47 Million TWD -20.416%
Crystalvue Medical Corporation 149.73 Million TWD -10.559%
Perfect Medical Industry Co., Ltd. 115.48 Million TWD -43.35%
Lagis Enterprise Co., Ltd. 112.36 Million TWD -47.326%
Amed Co., Ltd. 157.32 Million TWD -5.222%